secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2022-04-06T23:59:59+00:00
Accession:  0001140361-22-013398
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

First Wave BioPharma CMO James Pennington to retire, will consult until successor named
--------------------------------------------------------------------------------

- James Pennington, M.D., Chief Medical Officer, informed company of retirement on March 31, 2022.
- No disagreement with operations, policies, or practices was cited in the notice.
- Pennington will transition to a consultant role until a new CMO is appointed.
- Successor has not yet been announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000114036122013398/0001140361-22-013398-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000114036122013398/brhc10036192_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-22-013398

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer